Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Laboratory Services

 

Swedish private sector could face restrictive rules as early as 2015

The new minority Social Democrat government has published a radical manifesto, which could eradicate the for-profit sector from the Swedish healthcare, care and education landscape. A commission will report back by March 2016. We look at the manifesto and analyse the likely impact immediately and, also, in 2-3 years time. Prof Anders Anell at Lund University reckons for-profit could face new restrictions in early 2015.

French lab market shrinks by 1%, as government gives up on reform

Social security reimbursements for French lab tests fell 1% in the first seven months of 2014, following a drop of 0.8% for calendar 2013. Does this mean that the government will halt its annual price cut of nearly 3%? Meanwhile, the government has retreated from radical plans, which would have seen a liberalisation of the biologiste profession which controls the lab sector in France.

Will France liberalise pathology, pharmacies and dentistry?

The French liberal professions have reacted with fury to a set of proposed reforms which would allow private capital to invest in diagnostic labs and pharmacies. Other proposals would end restricted intake, which restricts access to training for dentists and might give a wider role to non-dentists such as hygienists and technicians. The report, compiled in March 2013 by the Inspection Générale des Finances, was only published in September 2014. But does it have a hope in Hell of becoming law?

Euromedic achieves stable ownership

Euromedic, Europe’s largest imaging service provider, has seen Ares Life Sciences, ultimately owned by Swiss billionaire Ernesto Bertarelli, buy out its fellow Euromedic shareholder, Montagu Investments. The deal means that Euromedic will not have to go through a trade sale or an IPO.

FREE BLOG Fleury: Building a brand around services

I had a fascinating chat with Rogerio Rabelo, a member of the board of directors at Fleury, one of the largest lab + imaging groups in Brazil. The company which is quoted has sales of around US$800 million and is perceived as a premium brand in Brazil, where some 50m people, a quarter of the population, have private healthcare plans giving access to private providers.

Enel-Med sells seven diagnostics centres to Bupa for €14m

Enel-Med, the third largest private healthcare chain in Poland has sold subsidiary Centrum Medyczne Diagnostyka Sp., made up of seven diagnosis centres, to Lux-Med, the largest Polish private chain recently bought by Bupa. We talk to Adam Rozwadowski, President of the Management Board of Enel-Med about what he will do with the money. Enel-Med wants […]

Interview: Emmett Moriarty, Consultant

The amount Russians spend privately on healthcare services has doubled in five years and EBITDA margins can reach 40-50% for operators, yet the market remains deeply fragmented with many fairly unsophisticated operators and no national chains. Emmett, a former VP at Medsi, the biggest Russian healthcare group, has a decade’s experience of investing in healthcare services in Russia and Eastern Europe and now works both for investors and for operators. The former sector leader for health at IFC, the commercial bank arm of the World Bank (and world’s largest investor in emerging markets healthcare), Emmett was previously head of KPMG’s Healthcare Performance Improvement division.

Bupa acquisitions on track, CEO tells Healthcare Europa

Bupa’s £1.6bn, 18 month-long M&A orgy is paying off, says CEO Stuart Fletcher. Announcing first half 2014 results for the international insurer and healthcare provider, he claimed: “Acquisitions are inline with our expectations.” But the UK remains tricky. Bupa is pruning its UK care home network and the amount of PMI bought by individuals continues to fall.

Find Us